Paper16631238
Patterns and frequency of recurrences of squamous cell carcinoma of the vulva.
Woolderink JM and 5 others. Gynecol Oncol, 2006. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. Patterns and frequency of recurrences of squamous cell carcinoma of the vulva. Papers, record 16631238. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16631238
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Squamous Cell | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Vulvar Neoplasms | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Female | |
| Humans | |
| Lymph Node Excision | |
| Lymphatic Metastasis | |
| Middle Aged | |
| Neoplasm Staging | |
| Retrospective Studies |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42503484 | Risk Factors for Recurrence in Vulvar Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. | Cancer Med | 2026 | https://conductscience.org/library/papers/42503484 | PubMed |
| 41716116 | Depth of Invasion of 13 mm or Greater Accurately Predicted the Risk of Having a Node Positivity in Lymphadenectomy for Squamous Vulvar Cancer. | J Obstet Gynaecol Res | 2026 | https://conductscience.org/library/papers/41716116 | PubMed |
| 41530618 | Electrochemotherapy as a symptom-oriented palliative treatment option: an exploratory single-center study in 15 patients with locally advanced or locoregionally recurrent vulvar carcinoma. | Arch Gynecol Obstet | 2026 | https://conductscience.org/library/papers/41530618 | PubMed |
| 39988466 | Mohs Micrographic Surgery Versus Wide Local Excision in the Treatment of Anogenital Squamous Cell Carcinoma: A Systematic Review. | Int J Dermatol | 2025 | https://conductscience.org/library/papers/39988466 | PubMed |
| 37507545 | Incidence of inguinofemoral lymph node metastases at the first local recurrence of vulvar cancer: a Dutch nationwide study. | Br J Cancer | 2023 | https://conductscience.org/library/papers/37507545 | PubMed |
| 37369376 | European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023. | Int J Gynecol Cancer | 2023 | https://conductscience.org/library/papers/37369376 | PubMed |
| 36199909 | Necrotizing fasciitis arising from squamous cell carcinoma of the vulva. | Dermatol Reports | 2022 | https://conductscience.org/library/papers/36199909 | PubMed |
| 34910394 | An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva. | J Gynecol Oncol | 2022 | https://conductscience.org/library/papers/34910394 | PubMed |
| 34898540 | Management of Clitoral Melanoma Presenting as an Exophytic Clitoral Mass: A Case Report and Review of the Literature. | Curr Oncol | 2021 | https://conductscience.org/library/papers/34898540 | PubMed |
| 34359760 | Superficially Invasive Vulvar Squamous Cell Carcinoma: A 37-Year-Long Experience of a Tertiary Referral Center. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34359760 | PubMed |
| 33650029 | The role of brachytherapy (interventional radiotherapy) for primary and/or recurrent vulvar cancer: a Gemelli Vul.Can multidisciplinary team systematic review. | Clin Transl Oncol | 2021 | https://conductscience.org/library/papers/33650029 | PubMed |
| 31823036 | Cerebral metastasis in recurrent squamous cell carcinoma of the vulva: case report and review of the literature. | Arch Gynecol Obstet | 2020 | https://conductscience.org/library/papers/31823036 | PubMed |
| 31355032 | A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression. | Case Rep Oncol Med | 2019 | https://conductscience.org/library/papers/31355032 | PubMed |
| 27765958 | Diagnosis, Therapy and Follow-up Care of Vulvar Cancer and its Precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015. | Geburtshilfe Frauenheilkd | 2016 | https://conductscience.org/library/papers/27765958 | PubMed |
| 26985195 | Interstitial high-dose-rate brachytherapy in locally advanced and recurrent vulvar cancer. | J Contemp Brachytherapy | 2016 | https://conductscience.org/library/papers/26985195 | PubMed |
| 25848321 | Vulvar cancer: epidemiology, clinical presentation, and management options. | Int J Womens Health | 2015 | https://conductscience.org/library/papers/25848321 | PubMed |
| 23263173 | Prognostic factors and a value of 2009 FIGO staging system in vulvar cancer. | Arch Gynecol Obstet | 2013 | https://conductscience.org/library/papers/23263173 | PubMed |
| 17310353 | [Lymphadenectomy of the inguinal region and pelvis]. | Chirurg | 2007 | https://conductscience.org/library/papers/17310353 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16631238
GET https://conductscience.org/api/papers/v1/16631238/authors